Rare diseases
Investigational molecules
Locations
Back to Italy2 668 clinical trials in Ranica, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of CFT1946 alone and with trametinib or cetuximab in patients with BRAF-V600 mutant solid tumors who have received standard treatment
ItalyStudy on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
ItalyStudy to Evaluate the Effectiveness of Spesolimab for Patients with Moderate to Severe Hidradenitis Suppurativa
ItalyStudy on BI 685509 and Empagliflozin for Patients with Portal Hypertension in Compensated Cirrhosis
ItalyStudy on the Effects of Volrustomig and Drug Combination for Patients with Advanced Hepatobiliary Cancer
ItalyStudy on BIA 28-6156 for Parkinson's Disease in Patients with GBA1 Gene Variant
ItalyStudy on the Effects of Ecopipam Hydrochloride for Children and Adolescents with Tourette's Disorder
ItalyStudy of Pembrolizumab with Chemoradiotherapy for Patients with Muscle-Invasive Bladder Cancer
ItalyStudy on the Effects of MK-5475 for Adults with Pulmonary Arterial Hypertension
ItalyStudy on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment
ItalyStudy on the Safety and Effectiveness of RGN-259 Eye Drops for Patients with Neurotrophic Keratopathy
ItalyStudy on KTE-X19 CAR-T Cell Therapy for Patients with Relapsed or Refractory Mantle Cell Lymphoma Responding Partially to Ibrutinib
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on membranoproliferative glomerulonephritis and related conditions, evaluating novel therapeutic approaches including iptacopan and pegcetacoplan for treating various forms of kidney inflammation.
Multiple trials aim to reduce proteinuria and improve long-term kidney function outcomes.
Comprehensive studies examining treatments for IgA Nephropathy and membranous nephropathy, including investigations of sparsentan and specialized antibody therapies for patients resistant to conventional treatments.
Focus on proteinuria reduction and preservation of renal function in various nephropathy types.
Advanced research into non-diabetic chronic kidney disease, exploring new therapeutic options including finerenone and investigating treatments for complications like hyperkalemia.
Studies aim to delay disease progression and improve standard of care outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
